Artiva Biotherapeutics, Inc. Common Stock

ARTVNASDAQUSD
11.77 USD
0.00 (0.01%)🟢PRE MARKET (AS OF 07:36 AM EDT)
🟢Market: OPEN

ARTV is currently priced at $11.77. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest ARTV is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Aug 26, 2026.

Open?$11.75
High?$11.77
Low?$11.75
Prev. Close?$11.77
Volume?32
Avg. Volume?348.0K
VWAP?$11.75
Rel. Volume?0.00x
Bid / Ask
Bid?$9.19 × 100
Ask?$13.43 × 100
Spread?$4.24
Midpoint?$11.31
Valuation & Ratios
Market Cap?575.4M
Shares Out?48.9M
Float?13.6M
Float %?27.9%
P/E Ratio?N/A
P/B Ratio?1.66
EPS?-$1.86
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Employees
115
Market Cap
575.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-07-19
Address
5505 MOREHOUSE DRIVE
SAN DIEGO, CA 92121
Phone: (858) 267-4467
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
40
Piotroski F-Score?0/9Weak
Altman Z-Score?15.14Safe
Confidence?41%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.37%High
Short Interest?2.1M
Days to Cover?6.1
Free Float13.6M
Avg Daily Volume345.5K
Settlement Date2026-08-14
Financial Health
Current Ratio?24.16Strong
Quick Ratio?24.16Strong
Cash Ratio?20.67Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
83
1.66CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-2.9CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
7
-26.1%WEAK
ROA?
S&P
3
-24.6%WEAK
Cash Flow & Enterprise
FCF?$-76910000
Enterprise Value?$274.0M
Fundamentals ratios updated end of day